These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35494077)

  • 1. A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
    Wang M; Dong C; Gao Y; Li J; Han M; Wang L
    Front Oncol; 2022; 12():844978. PubMed ID: 35494077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates.
    Li Z; Zhang J; Han J; Wang Q; Sun H; Zhang Z; Liu T; Che Y; Wang J; Wang J; Xu L; Pan L; Li L
    Int J Lab Hematol; 2024 Dec; 46(6):1077-1083. PubMed ID: 39019548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA.
    Kimura K; Tabe Y; Ai T; Takehara I; Fukuda H; Takahashi H; Naito T; Komatsu N; Uchihashi K; Ohsaka A
    Sci Rep; 2019 Sep; 9(1):13385. PubMed ID: 31527646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
    Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of acute myeloid leukemia M1 and M2 subtypes using machine learning.
    Liu K; Hu J
    Comput Biol Med; 2022 Aug; 147():105741. PubMed ID: 35738057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
    Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired aplastic anemia developing myelodysplastic syndrome/acute myeloid leukemia: clinical analysis of nineteen patients and literatures review].
    Ma L; Li X; Zhang J; Shao Y; Nie N; Huang Z; Ge M; Zheng Y; Qu D; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):216-20. PubMed ID: 25854465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed criteria for classification of acute myeloid leukemia in dogs and cats.
    Jain NC; Blue JT; Grindem CB; Harvey JW; Kociba GJ; Krehbiel JD; Latimer KS; Raskin RE; Thrall MA; Zinkl JG
    Vet Clin Pathol; 1991; 20(3):63-82. PubMed ID: 12673541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of m6A regulators to predict transformation from myelodysplastic syndrome to acute myeloid leukemia via machine learning.
    Ma J; Zhao H; Ge F
    Medicine (Baltimore); 2024 Jul; 103(28):e38897. PubMed ID: 38996166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
    Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Assessment of Bone Marrow Activity Using 18 F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes.
    Tasaki T; Tsujikawa T; Hosono N; Mori T; Makino A; Kiyono Y; Okazawa H; Yamauchi T
    Clin Nucl Med; 2022 Dec; 47(12):1048-1055. PubMed ID: 36190714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ferrokinetics and bone marrow scanning in patients with myelodysplastic syndrome, hypoplastic myelodysplastic syndrome and aplastic anemia].
    Ohno Y; Takahashi Y; Yoshida Y
    Rinsho Ketsueki; 1993 Mar; 34(3):260-4. PubMed ID: 8479076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying Bone Marrow Fat Fraction and Iron by MRI for Distinguishing Aplastic Anemia from Myelodysplastic Syndromes.
    Zeng Z; Ma X; Guo Y; Ye B; Xu M; Wang W
    J Magn Reson Imaging; 2021 Dec; 54(6):1754-1760. PubMed ID: 34117662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aplastic anemia evolving into overt myelodysplastic syndrome/acute myeloid leukemia with t(3;5)(p25;q31).
    Kawata E; Kuroda J; Kimura S; Kamitsuji Y; Kobayashi Y; Yoshikawa T
    Cancer Genet Cytogenet; 2002 Sep; 137(2):91-4. PubMed ID: 12393278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.
    Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H
    Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.